BMS’ Opdivo plus Yervoy fails to improve OS in lung cancer study

Image: BMS’ Opdivo plus Yervoy has failed to improve OS in CheckMate lung cancer study. Photo: courtesy of renjith Krishnan / FreeDigitalPhotos.net.